Zusammenfassung
Hintergrund
Die pigmentierte villonoduläre Synovialitis (PVNS) ist eine seltene proliferative Erkrankung der Binnenhaut großer und kleiner Gelenke. Um ein optimales Behandlungsergebnis zu erzielen, sind eine spezifische Diagnostik und ein gezieltes therapeutisches Vorgehen notwendig.
Fragestellung
Die vorliegende Arbeit soll eine Übersicht über Epidemiologie, Ätiopathogenese und Diagnostik der PVNS liefern sowie aktuelle Therapie- und Behandlungsempfehlungen aufzeigen.
Material und Methoden
Es erfolgte eine systematische Literaturrecherche über die Datenbank des National Center for Biotechnological Information (http://www.ncbi.nlm.nih.gov/pubmed). Gegenstand der Suche waren unabhängig von der Evidenz der jeweiligen Arbeiten randomisierte klinische und experimentelle Studien, systematische und nichtsystematische Übersichtsarbeiten, Expertenmeinungen sowie Fallberichte bezüglich der PVNS.
Ergebnisse
Die Differenzialdiagnose der PVNS sollte v. a. bei rezidivierenden blutigen Gelenkergüssen bedacht werden. Die Ursache der Erkrankung ist bis heute nicht genau geklärt. Die endgültige Diagnose kann letztlich nur histologisch gestellt werden. Um repräsentatives histologisches Gewebe für die Diagnose zu gewinnen, sollte im Vorfeld der Probeentnahmen ein MRT mit den entsprechenden Häm-Sequenzen durchgeführt werden. Die Erkrankung neigt abhängig von den verschiedenen Formen zu einer hohen Rezidivrate. Therapeutisch sollte deshalb eine vollständige Synovektomie erfolgen.
Diskussion
Als operatives Vorgehen werden arthroskopische und offene Verfahren beschrieben, die z. T. kontrovers hinsichtlich Komplikations- und Rezidivrate diskutiert werden. Adjuvante interventionelle Therapieformen wie die Radiosynoviorthese werden zur Senkung der Rezidivquote empfohlen.
Abstract
Background
Pigmented villonodular synovitis (PVNS) describes a rare disease caused by an abnormal proliferation of the synovial membrane in large and small joints. In order to achieve an optimal result of treatment it is necessary to carry out specific diagnostics and a targeted therapy approach.
Objective
This article gives a review of the epidemiology, etiopathogenesis and diagnostic management of PVNS as well as presenting the current therapy and treatment recommendations.
Material and methods
A systematic search of the literature was performed in the databank of the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/pubmed). The search targeted randomized clinical and experimental studies, systematic and non-systematic review articles, expert opinions and case reports related to PVNS, independent of the level of evidence attained by each study.
Results
The differential diagnosis of PVNS should be considered in cases of recurrent hemorrhagic joint effusions. The cause of the disease has not yet been exactly clarified. The final diagnosis can ultimately only be confirmed by histological investigations. In order to obtain representative histological tissue samples for the diagnosis, magnetic resonance imaging (MRI) with the appropriate heme sequences should be carried out prior to taking samples. The management of PVNS is often difficult due to the high risk of recurrence depending on the various forms. In view of the high rate of recurrence, therapy should include a complete synovectomy.
Conclusion
For the surgical approach arthroscopic and open procedures have been described, which are currently controversially discussed with respect to the complication and recurrence rates. Adjuvant interventional therapy forms, such as radiosynoviorthesis are recommended to reduce the recurrence rate.
Literatur
Ankerhold J, von Torklus D (1973) Pigmentierte villonoduläre Synovitis. Fortschr Med 91:1307–1311
Berger I, Aulmann S, Ehemann V, Helmchen B, Weckauf H (2005) Apoptosis resistance in pigmented villonodular synovitis. Histol Histopathol 20:11–17
Blanco CE, Leon HO, Guthrie TB (2001) Combined partial arthroscopic synovectomy and radiation therapy for diffuse pigmented villonodular synovitis of the knee. Arthroscopy 17:527–531
Böhme PE (1968) Die pigmentierte villo-noduläre Synovitis. Chir Prax 12:581
Burkart A, Imhoff AB (2005) Pigmentierte villonoduläre Synovialitis (PVNS). In: Kohn D (Hrsg) Orthopädie und orthopädische Chirurgie: Knie. Thieme, Stuttgart, S 207–209
Byers PD, Cotton RE, Deacon OW, Lowy M, Newmann PH, Sissons HA, Thomson AD (1968) The diagnosis and treatment of pigmented villonodular synovitis. J Bone Jt Surg 50-B:290–305
Calmet J, Hernandez-Hermoso J, Gine J, Jimeno F (2003) Localized pigmented villonodular synovitis in an unusual location of the knee. Arthroscopy 19:144–149
Cassier PA, Gelderblom H, Stacchiotti S, Thomas D, Maki RG, Kroep GR, van der Graaf WT, Italiano A, Seddon B, Domont J, Bompas E, Wagner AJ, Blay JY (2012) Efficacy of imatinib mesylate for the treatmentof localy advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis. Cancer 118:1649–1655
Chaissaignac M (1852) Cancer de la gaine des tendons. Gaz Hop Civ Milit 47:185
Chiari C, Pirich C, Brannath W, Kotz R, Trieb K (2006) What affects the recurrence and clinical outcome of pigmented villonodular synovitis? Clin Orthop 450:172–178
Darling JM, Glimcher LH, Shortkoff S, Albano B, Gravallese EM (1994) Expression of metalloproteinases in pigmented villonodular synovitis. Hum Pathol 25:825–830
Delcogliano A, Galli M, Menghi A, Belli P (1998) Localized pigmented villonodular synovitis oft he knee: report oftwo cases of fat pad involvement. Arthroskopy 14(5):527–531
Dorwart RH, Genant HK, Johnston WH, Morris JM (1984) Pigmented villonodular synovitis of synovial joints: clinical, pathologic and radiologic features. Am J Roentgenol 143:877–885
Finis K, Sültmann H, Ruschhaupt M, Buness A, Helmchen B, Kuner R, Gross ML, Fink B, Schirmacher P, Poustka A, Berger I (2006) Analysis of pigmented villonodular synovitis with genome-wide complementary DNA microarray and tissue array technology reveals insight into potential novel therapeutic approaches. Arthritis Rheum 54(3):1009–1019
Flandry FC, Jacobson KE, Andrews JR (1986) Localized pigmented villonodular synovitis of the knee mimicking meniscal injury. Arthroscopy 2:217–221
Gallacchi G (1983) Beitrag zur pigmentierten villonodulären Synovitis. Schweiz Med Wochenschr 113:1033–1037
Geiger EV, Reize P, Rudert M, Wülker N (2005) Die pigmentierte villonoduläre Synovitis – eine diagnostische Herausforderung. MMW Fortschr Med 147:153–157
Granowitz SP, D’Antonio J, Mankin HL (1976) The pathogenesis and long-term results of pigmented villonodular synovitis. Clin Orthop 114:335–351
Griffin AM, Ferguson PC, Catton CN, Chung PW, White LM, Wunder JS (2012) Long term outcome of the treatmentof high risktenoaynovial giant cellTumor/pigmented villonodular synovitis with radiotherapy and surgery. Cancer 118:4901–4909
Imhoff A, Schreiber A (1988) Ätiologie und Pathogenese der Synovitis villonodosa pigmentosa. Orthopäde 17:223–232
Jacques W (1968) Ergebnisse klinischer Synopsis der pigmentierten villo-nodulären Synovitis der Gelenke unter besonderer Berücksichtigung der Krankheitsdauer. Dissetationsarbeit, Hamburg
Jaffe HL, Liechtenstein L, Sutro CI (1941) Pigmented villonodular synovitis, bursitis and tendosynovitis. Arch Pathol 31:731–765
Johannson JE, Ajjoub S, Coughlin LP, Wener JA, Cruess RL (1982) Pigmented villonodular synovitis of joints. Clin Orthop 163:159–166
Krenn V, Morawietz L, König A, Haeupl T (2006) Differential diagnosis of chronic synovitis. Pathologe 27(6):402–408
Lee BI, Yoo JE, Min KD (1998) Localized pigmented villonodular synovitis of the knee: arthroscopic treatment. Arthroscopy 14(7):764–768
Musculo DL, Makino A, Costa-Paz M, Ayerza MA (2000) Magnetic resonance imaging evaluation and arthroscopic resection of localized pigmented villonodular synovitis of the knee. Orthopedics 23:367–369
Myers B, Masi A, Feigenbaum S (1980) Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of one hundred and sixty-six cases and literature review. Medicine 59:223–228
Oehler S, Fassbender HG, Neureiter D, Meyer-Scholten C, Kirchner T, Aigner T (2000) Cell populations involved in pigmented villonodular synovitis of the knee. J Rheumatol 27:463–470
Ohjimi Y, Iwasaki H, Ishiguro M, Kaneko Y, Tashiro H, Emoto G, Ogata K, Kikuchi M (1996) Short arm of chromosome 1 aberration recurrently found in pigmented villonodular synovitis. Cancer Genet Cytogenet 90:80–85
Parikh SN, Chen AL, Ergas E (2002) Localized pigmented villonodular synovitis: arthroscopic diagnosis and Management of an “invisible” lesion. Arthroscopy 18(6):E 31
Rao AS, Vigorita VJ (1984) Pigmented villonodular synovitis (Giant cell tumor of the Tendon sheats and synovial membrane). J Bone Jt Surg 66:76–94
Rodriguez-Merchant EC (2014) Open versus arthroscopic synovectomy for pigmented villonodular synovitis of the knee. J Orthop Surg (Hong Kong) 22(3):406–408 (Review article)
Rosa MA, Galli M, Fadda G, Maggiano N, Gambino GF (2000) Proliferating cell nuclear antigen labelling index in localized pigmented villonodular synovitis and its relationship to the size of nodules. Int Orthop 24:197–201
Saxena DPM, Hugo Perez DPM (2004) Pigmented villonodular synovitis about the Ankle: a review of literature and Presentation in 10 athletic patients. Foot Ankle Int 25:819–826
Schwartz HS, Unni KK, Pritchard DJ (1989) Pigmented villonodular synovitis. A retrospective review of affected large joints. Clin Orthop 247:243–255
Shabat S, Kollender Y, Merimsky O, Isakov J, Flusser G, Nyska M (2002) The use of surgery and yttrium 90 in the management of extensive and diffuse pigmented villonodular synovitis of large joints. Rheumatology 41:1113–1118
Sharma H, Rana B, Mahendra A, Jane MJ, Reid R (2007) Outcome of 17 pigmented villonodular synovitis (PVNS) of the knee at 6 years mean follow-up. Knee 14:390–394
Simon G (1865) Extirpation einer sehr grossen, mit dickem Stiele angewachsenen Knieggelenkmaus mit glücklichem Erfolge. Arch Klin Chir 6:573
Söder S, Sesselmann S, Aigner T, Oehler S, Agaimy A (2015) Tenosynovial giant cell tumour (pigmented villonodular synovitis-)like changes in periprosthetic interface membranes. Virchows Arch. doi:10.1007/s00428-015-1874-9. (Epub ahead of print)
Temple HT (2012) Pigmented villonodular synovitis therapy with MSCF-1 inhibitors. Curr Opin Oncol 24(4):404–408
Weber U, Müller K (1984) Periphere Weichteiltumoren. In: Witt AN, Rettig H, Schlegel KF, Hackenbroch M, Hupfauer W (Hrsg) Orthopädie in Praxis und Klinik, Bd. III/2. Thieme, Stuttgart, S 2.62–2.63
Weckauf H, Helmchen B, Hinz U, Meyer-Scholten C, Aulmann S, Otto HF, Berger I (2003) Expression of cell cycle-related gene products in different forms of primary versus recurrent PVNS. Cancer Lett 210:111–118
Winter R (1979) Die pigmentierte villo-noduläre Synovitis. Ein klinischer Erfahrungsbericht. Chir Prax 26:457
Wiss DA (1980) Recurrent villonodular synovitis oft he knee. Succesfull treatment with Yttrium-90. Clin Orthop 169:139–144
Xie GP, Jiang N, Liang CX, Zeng JC, Chen ZY, Xu Q, Qi RZ, Chen YR, Yu B (2015) Pigmented villonodular synovitis: a retrospectivemulticenter study of 237 cases. PloS One 10(3):e01211451 doi:10.1371/journal.pone 01211451
Yoon HJ, Cho JA, Lee JI, Hong SP, Hong SD (2011) Malignant pigmented villonodular synovitis of the temporomandibular joint with lung metastases: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111:e30–e36 (pmid: 21444225) doi:10.1016/j.tripleo.2010.11.031.
Zhao X, Ji W, Qian X, Lu Y (2014) Pigmented villonodular synovitis developing in a patient with rheumatoid arthritis. J Clin Rheumatol 20(5):283–286
Zvijac JE, Lau AC, Hechtman KS, Uribe JW, Tjin-A-Tsoi EW (1999) Arthroscopic treatment of pigmented villonodular synovitis of the knee. Arthroscopy 15:613–617
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
K. A. Jendrissek, T. Hotfiel, B. Swoboda, S. Söder und R. Janka geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Additional information
Redaktion
B. Manger, Erlangen
B. Swoboda, Erlangen
Rights and permissions
About this article
Cite this article
Jendrissek, K.A., Hotfiel, T., Swoboda, B. et al. Pigmentierte villonoduläre Synovialitis. Z Rheumatol 75, 157–165 (2016). https://doi.org/10.1007/s00393-015-0028-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-015-0028-4